TokyoTokyo Mon - Fri 10:00-18:00 +81 (368) 662-975
info@mountequitygroup.com

Antibe Therapeutics to Present at Upcoming Virtual Investor Conferences

Mount Equity Group Tokyo, Japan > News > Markets > Antibe Therapeutics to Present at Upcoming Virtual Investor Conferences

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for a wide range of inflammatory conditions, today announced its participation in the following U.S.-based virtual investor conferences in June:

2021 LD Micro Invitational XI, Live company presentation by Scott Curtis, Executive VP, and Dr. Joseph Stauffer, Chief Medical Officer, on Wednesday, June 9, 2021 at 12:30 pm (Eastern Time).

Raymond James Human Health Innovation Conference, Live company presentation by Dan Legault, CEO, and Dr. Joseph Stauffer on Wednesday, June 23, 2021 at 8:40 am (Eastern Time).

A link to the webcast of each event will be available on the News and Events section of the Company’s website at antibethera.com. Following the presentations, a replay of the webcasts will be available on the website for 90 days.

About Antibe Therapeutics Inc.

Antibe is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to address inflammation arising from a wide range of medical conditions. The Company’s current pipeline includes three assets that seek to overcome the gastrointestinal (“GI”) ulcers